BlackThorn Therapeutics, Inc.

ACTIVE

780 Brannan St, 加利福尼亚州旧金山县, California, United Stateswww.blackthornrx.comSubsidiary11–50 employeesEstablished: 2015-01-01

Part of Neumora Therapeutic

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

66.7%

Phase 1

33.3%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (6)

BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations

Phase 2

Completed

interventional

Aug 201824 participants

BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder

Phase 2

Completed

interventional

Jun 2017104 participants

A Study of LY2940094 in Participants With Alcohol Dependency

Phase 2

Completed

interventional

Jul 201388 participants

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Phase 2

Completed

interventional

Nov 2012136 participants

A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects

Phase 1

Completed

interventional

Jul 201112 participants

A Study of LY2940094 in Major Depressive Disorder

Phase 1

Completed

interventional

Dec 201066 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations